Aller au contenu principal
Accès ouvert déclaré 2026 article

Surgical Site Infections in Major Lower Limb Amputation (SIMBA): international multicentre study

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

INTRODUCTION: Surgical site infection (SSI) after major lower limb amputation (MLLA) significantly affects function, mobility, morbidity, and mortality, alongside broader impacts on healthcare services. Limited data exist on the incidence, prevention, and management of SSI after MLLA. Improving outcomes and wound healing have been identified as research priorities for patients following MLLA. METHODS: Surgical Site Infection in Major Lower Limb Amputation (SIMBA) is an international, prospective, collaborative observational study. Data were collected for consecutive patients undergoing MLLA over 8 months, with 30-day follow-up. Outcomes included the incidence of SSI (defined using Centers for Disease Control and Prevention criteria), wound dehiscence (defined as any partial or complete separation of the incision or flap, with or without infection), further intervention, mortality, adjunct use, and SSI predictors. RESULTS: Validated data for 1314 MLLAs from 46 centres in the UK (34), Europe (9), Australasia (2), and Asia (1) were collected, comprising 643 (48.9%) transfemoral, 41 (3.1%) through-knee, and 628 (47.8%) transtibial amputations. The most common indications were ischaemia (56.6%, 742) and uncontrolled infection (22.3%, 293). The incidences of SSI and wound breakdown were 10.9% (135 of 1238) and 16.7% (204 of 1217), respectively. Low glomerular filtration rate, cardiac disease, dirty/infected wound class, and transtibial amputations were independent predictors of SSI. SSI was associated with increased postoperative morbidity, wound breakdown, further intervention, and delays in fitness for discharge. The 30-day mortality rate was 7.0% (92 of 1314), with no significant association with SSI. CONCLUSION: SSI and wound breakdown are common following MLLA, and are associated with increased morbidity, delayed recovery, and revision surgery. These findings identify patient- and procedure-specific factors associated with elevated SSI risk, and a lack of procedure-specific evidence, revealing critical gaps in SSI prevention strategies. Addressing these are essential to improve patient outcomes, reduce healthcare costs, and guide future research.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Surgical Site Infections in Major Lower Limb Amputation (SIMBA): international multicentre study
Date Crossref
04/09/2026
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Diabetic Foot Ulcer Assessment and ManagementSurgical site infection preventionProsthetics and Rehabilitation Robotics

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.